The COVID-19 XPRIZE and the need for scalable, fast, and widespread testing

Affiliations

• ¹ Department of Physiology and Biophysics, Weill Cornell Medical College, New York, NY, USA.
• ² The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY, USA.
• ³ The WorldQuant Initiative for Quantitative Prediction, Weill Cornell Medicine, New York, NY, USA.
• ⁴ Joint Initiative for Metrology in Biology, Stanford, CA, USA.
• ⁵ Ginkgo Bioworks, Cambridge, MA, USA.
• ⁶ Resilience Health, New York, NY, USA.
• ⁷ Cowen and Company, Boston, MA, USA.
• ⁸ Manchester Institute of Biotechnology, University of Manchester, Manchester, UK.
• ⁹ Harvard Medical School, Cambridge, MA, USA.
• ¹⁰ Shenzhen Institutes of Advanced Technology, Shenzhen, China.
• ¹¹ OpenCovidScreen, San Francisco, CA, USA.
• ¹² HudsonAlpha Institute for Biotechnology, Huntsville, AL, USA.
• ¹³ Stanford Genome Technology Center West, Palo Alto, CA, USA.
• ¹⁴ Medical College of Wisconsin, Milwaukee, WI, USA.
• ¹⁵ Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
• ¹⁶ Department of Physiology and Biophysics, Weill Cornell Medical College, New York, NY, USA. chm2042@med.cornell.edu.
• ¹⁷ The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY, USA. chm2042@med.cornell.edu.
• ¹⁸ The WorldQuant Initiative for Quantitative Prediction, Weill Cornell Medicine, New York, NY, USA. chm2042@med.cornell.edu.
• ¹⁹ The Feil Family Brain and Mind Research Institute, New York, NY, USA. chm2042@med.cornell.edu.